Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Mizuho from $223.00 to $235.00. They now have a "neutral" rating on the stock.
Global PEGylated Proteins Market Report 2024: Revenue Data for 2021-2022, Estimates for 2023, Forecasts for 2024, and CAGR Projections through 2028 [Yahoo! Finance]
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income [Yahoo! Finance]
Company News for May 6, 2024 [Yahoo! Finance]
Investors Pile Into Amgen in Search of Next Obesity Drug Payout [BNN Bloomberg (Canada)]